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Olfactory function has been shown to be affected in chronic
kidney disease; however, studies are contradictory and
little is known on the effects of dialysis. To resolve these
issues we tested olfactory function in 24 healthy controls
and in 28 patients with chronic kidney disease receiving
hemodialysis (20 patients) or peritoneal dialysis (the other 8).
As assays for olfactory function we measured smell
identification, n-butanol and acetic acid thresholds, Kt/V urea,
percentage reduced urea, and weights before and after
dialysis. Olfactory function was also self-rated by the
participants. Compared to healthy controls, predialysis
olfactory function was moderately but significantly decreased
in the two dialysis groups, with hemodialysis patients
being more affected. Patients self-rated olfactory function
similar to that of healthy controls, suggesting that patients
are unaware of the olfactory decrease. Olfactory function
was significantly improved by one hemodialysis session.
Neither body mass index, total volume loss, nor any other
dialysis parameter correlated with olfactory function or its
restitution following hemodialysis. The observed pattern
of improvement suggests underlying mixed peripheral and
central mechanisms. Thus, olfactory dysfunction in patients
with chronic kidney disease is readily reversible by
hemodialysis.
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Olfactory disorders are more common in the general
population than previously assumed.1 It is believed that
many individuals affected by olfactory loss are either not
aware of their impairment or not sufficiently disturbed by it
to seek medical advice. Apart from the classical causes of
olfactory impairment, such as upper respiratory tract
infections, head trauma, and sinonasal olfactory diseases,
numerous neurological and general systemic pathologies have
been identified.2,3 In contrast to subjects who lose their sense
of smell after upper respiratory tract infections, trauma, or
sinonasal diseases,4,5 the olfactory decline in systemic
pathologies often remains unnoticed by the patients.6–8
Diabetes8–10 and chronic kidney disease (CKD) are two
systemic pathologies that have been shown to severely alter
olfactory function.7,11,12 The olfactory impairments in CKD
patients are thought to contribute to the malnutrition and
appetite loss that characterize that illness.13–15 Interestingly,
olfactory impairment in CKD seems to be restricted to olfactory
identification and discrimination: thresholds are mostly un-
affected.7,11,16 This pattern suggests a central nervous origin.
Furthermore, olfactory dysfunction seems to be transient: after
kidney transplant, patients again exhibit olfactory function
similar to healthy control subjects.11 The rapidity of olfactory
recovery remains largely unknown, because the few studies that
have investigated olfactory function report contradictory
results.11,17–19 Most studies tested only one olfactory task.
The goal of the present study was to examine multiple
olfactory tasks before and after hemodialysis to investigate
to what extent hemodialysis modifies olfactory function.
A group of peritoneal dialysis patients was also studied.
This method of dialysis is characterized by significantly
fewer fluctuations in blood markers of uremia (such as urea,
creatinine, phosphates, and so on). The comparison of these
two groups might help to differentiate between the acute and
chronic effects of uremia.
RESULTS
Olfactory function in healthy control subjects (HCS) and
hemodialysis (HD), and peritoneal dialysis (PD) patients
When comparing the prehemodialysis olfactory function of
HD patients with that of HCS and PD patients, the HCS
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performed best and the HD patients worst (significant effect
for the factor ‘group’; F¼ 5.5, P¼ 0.007; Figure 1).
One-way analysis of variance (ANOVA) for each single
olfactory task (identification, n-butanol, or acetic acid
threshold) revealed that this decrease was mostly because of
olfactory identification (10±0.4 points (pts) in HCS,
9.6±0.2 pts in PD patients, and 8.2±0.7 pts in HD patients;
one-way ANOVA, F¼ 3.2, P¼ 0.04) and acetic acid thresh-
olds (15.5±0.1 pts in HCS, 14.4±0.4 pts in PD patients, and
13.1±0.7 pts in HD patients; one-way ANOVA, F¼ 7.5,
P¼ 0.001) but not n-butanol thresholds (8±0.3 pts in HCS,
7.5±0.5 pts in PD patients, and 6.9±0.7 pts in HD patients;
one-way ANOVA, F¼ 1.05, P¼ 0.35).
Effect of hemodialysis on olfactory function in HD patients
Comparing the pre- and post-hemodialysis olfactory func-
tion of HD patients revealed that the overall olfactory score
improved significantly 1 h after hemodialysis (t¼ 3.4,
P¼ 0.003). The post hoc analysis showed that olfactory
identification (from 8.2±0.7 pts before to 9.4±0.6 pts after
hemodialysis; t¼ 3.4; P¼ 0.003) and acetic acid thresholds
(prehemodialysis: 13.1±0.7 pts to posthemodialysis:
14.3±0.4 pts; t¼ 3.5; P¼ 0.002) improved significantly 1 h
after the hemodialysis session, whereas n-butanol thresholds
(prehemodialysis: 6.9±0.7 pts to posthemodialysis: 6.7±0.6
pts; t¼ 0.6; P¼ 0.5) remained unchanged after hemodialysis
(Figure 2). One hemodialysis session improved olfactory
identification by 14.5% and acetic acid thresholds by 9.1%.
Olfactory identification was within the normal range
(compared with HCS; t¼ 1.3; P¼ 0.2), but hemodialysis
did not completely reverse the decreased acetic acid thresh-
olds (compared with HCS; t¼ 2.6; P¼ 0.01).
Self-ratings of olfactory function and nasal patency in HD
patients and HCS
Comparing the HD patient’s ratings of nasal patency,
olfactory function, and importance attached to olfaction
with those of HCS revealed no significant differences
(Figure 3). Nasal patency was evaluated by HCS to be
7.2±0.5 pts and 7.3±0.5 by HD patients (t¼ 0.2; P¼ 0.9).
Olfactory function was evaluated by HCS to be 7.6±0.3 pts
and 7.7±0.6 by HD patients (t¼ 0.3; P¼ 0.8). Importance
attached to olfaction was the same in both groups (8.2±0.5
pts in HCS and 8.4±0.5 in HD patients; t¼ 0.4; P¼ 0.7).
Ratings of nasal patency significantly correlated with self-rated
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Figure 1 |Results of olfactory identification, n-butanol
threshold, and acetic acid threshold in the three investigated
groups (HCS, healthy control subjects; HD, chronic renal
failure undergoing hemodialysis; PD, patients undergoing
peritoneal dialysis). Overall olfactory performances were best in
healthy subjects with worse olfactory function in PD and again in
HD patients (analysis of variance (ANOVA), P¼ 0.007). Post hoc
analysis showed that only the decrease observed for olfactory
identification (P¼ 0.04) and acetic acid threshold (P¼ 0.001)
reached significance, whereas n-butanol thresholds (P¼ 0.35)
were not significantly different between the investigated groups.
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Figure 2 |Olfactory function before and 1h after the
hemodialysis (HD) in chronic kidney disease (CKD) patients.
After the hemodialysis, olfactory identification and acetic acid
thresholds improved significantly, whereas the n-butanol
threshold remained unaffected by the hemodialysis. NS, not
significant.
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Figure 3 |Ratings of nasal patency, olfactory function, and
importance attached to olfactory function in healthy control
subjects (HCS) and hemodialysis (HD) patients. Both patients
and HCS rated their nose to be equally free of obstruction, their
olfactory function to be above average, and both stated that
olfactory function was important for them. No significant
differences were seen in the ratings between the HD patients and
the HCS.
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olfactory function in HD patients (r20¼ 0.5; P¼ 0.03) but not
in HCS (r24¼ 0.2; P¼ 0.8).
Body mass index (BMI), urea, weight changes, and
hemodialysis parameters
Neither the BMI score (identification: r20¼ 0.3; P¼ 0.2;
acetic acid threshold: r20¼ 0.3; P¼ 0.3) nor total weight
changes (identification: r20¼0.2; P¼ 0.4; acetic acid
threshold: r20¼0.04; P¼ 0.8) during hemodialysis corre-
lated with the observed olfactory improvement.
The BMI correlated negatively with the Kt/V(urea)
(r20¼0.47; P¼ 0.042) and a trend was seen between
percentage of reduction in urea (PRU) and BMI
(r20¼0.45; P¼ 0.052). Kt/V(urea) and PRU correlated
significantly (r20¼ 0.92; Po0.001). In neither patients
undergoing hemodialysis (identification: r20¼0.1; P¼ 0.9;
acetic acid threshold: r20¼0.1; P¼ 0.3; n-butanol thresh-
old: r20¼ 0.15; P¼ 0.5) nor peritoneal dialysis (identification:
r20¼ 0.5; P¼ 0.2; acetic acid threshold: r20¼0.14; P¼ 0.7;
n-butanol threshold: r20¼0.3; P¼ 0.4) did the urea level
correlate with olfactory function.
Olfactory identification tested twice in HCS and HD patients
In order to test for memory effects, 21 of the 24 HCS and 14
HD patients underwent repeated olfactory identification
testing within 4 h. There was no improvement in olfactory
identification in either HCS or HD patients on the second
testing (HCS: t¼ 0.3; P¼ 0.76; HD: t¼ 1.1; P¼ 0.27;
Figure 4).
Literature
A literature search revealed 38 articles, and 8 matched the
criteria of olfactory testing in human subjects. The previous
findings on olfactory function in humans suffering from
chronic renal diseases have been extracted and summarized
in Table 1.
DISCUSSION
The main findings of the present study are that: (1) overall
olfactory function was decreased in CKD patients undergoing
HD or PD; (2) the observed decrease was greater in HD
patients than in PD patients; (3) the olfactory dysfunction in
CKD patients was often not noticed by the patients; (4) one
hemodialysis session improved olfactory function, and (5)
the observed pattern of improvement suggested mixed
peripheral and central mechanisms were involved. BMI, total
volume loss, and other dialysis parameters were not
correlated with the olfactory function or its improvement
after hemodialysis.
The present study confirmed the findings of Frasnelli
et al.7 who showed that CKD patients were unaware of their
olfactory dysfunction. Considering that their olfactory
dysfunction was not severe (it was decreased by only
10–20%), these findings fit perfectly well into the literature
reporting self-rating of olfactory performances. Although
anosmic subjects normally become aware of this loss, mild
variations around normal olfactory function remain mostly
unnoticed.4,20 Moreover, in cases of olfactory improvement
after olfactory dysfunction, changes must comprise415% of
the normal olfactory function to be noticed.21 Unfortunately,
we did not ask for ratings directly after the hemodialysis, but
it is doubtful that patients would have noticed a 10%
improvement.
Similar to the present results, most authors found overall
olfactory function to be decreased when compared with
healthy subjects (see Table 1). However, careful examination
of previous studies showed contradictory findings. For
suprathreshold tests, such as discrimination and identifica-
tion, olfactory function is generally reported to be decreased
in CKD patients and the present findings support this
assertion. Olfactory identification and discrimination testing
scores depend upon recognition and naming of odorants, in
contrast to the threshold tasks (n-butanol, acetic acid) that
are simple detection tasks. Thus, olfactory identification and
discrimination reflect more complex and higher cognitive
aspects of olfactory processing, compared with olfactory
threshold tests, which seem to reflect the peripheral olfactory
pathways.22,23 This has been supported by patterns of
olfactory dysfunction found in patients with chronic
sinounasal disease, who had decreased thresholds but normal
identification,22 and in patients with temporal lobe epilepsy,
where the findings were reversed.23 This latter pattern has
also been found by Frasnelli et al.7 and Korytowska and
Szmeja19 and led to speculation that olfactory impairment in
HD patients has its origin at a central nervous level.
We confirmed that HD patients have impaired odor
identification but our findings drew a slightly different
picture with regard to thresholds. Although n-butanol
thresholds were unaffected by chronic renal failure, acetic
acid thresholds were decreased. This suggested that chronic
renal failure affects peripheral odor sensitivity disproportion-
ately and this may also explain the divergent results that
previous authors had concerning thresholds (see Table 1).
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Figure 4 |Olfactory identification performances in healthy
control subjects (HCS) and hemodialysis (HD) patients on two
test sessions within 4h. The HD patients were tested twice
within 4 h without undergoing hemodialysis in between. No
learning effect could be observed within one repetition of the
olfactory identification test.
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This could indicate that CKD affects certain odor sensitivities
at peripheral and maybe olfactory receptor or olfactory
mucous membrane level,24 without lowering odor thresholds
globally. An alternative explanation for decreased acetic acid
thresholds could be that this odor also has a strong trigeminal
component. Previous studies on somatosensory perception
involving the trigeminal nerve showed greater effects on
peripheral compared with central pathways in CKD
patients.25 Thus, the acetic acid threshold decrease could be
a reflection of peripheral sensory neuropathy in CKD
patients. However, at low concentrations almost all trigem-
inal substances act as odorants and become truly trigeminal
stimulants only at higher concentrations, which make this
hypothesis questionable in the present case.26
From previous reports it is known that olfactory function
improves after successful kidney transplantation,11 indicating
that olfactory dysfunction in CKD is reversible. However, the
mechanisms of this recovery are largely unknown and effects
Table 1 | Summary of the findings on olfactory function in previous studies investigating humans suffering from chronic
kidney disease
Olfactory function compared to normal subjects
Authors
Number
of CRF
patients Threshold Discrimination Identification
Effect of
hemodialysis
tested
Observed
effect of
hemodialysis
on olfaction
Other
observations
Schiffman
et al.12
11 — Odor differences–
similarities
(multidimensional
scale)
— No — Food odors rated
less pleasant by
CRF patients
Vreman
et al.16
33 Pyridine
normal
— — No — Elevated threshold
for all four tastes
(acid, sweet, sour,
bitter) in CRF patients
Conrad
et al.17
16 — Yes–no odor
discrimination
task lower
— Yes Yes–no odor
discrimination
task worse
—
Corwin18 14 — Yes–no odor
discrimination
task lower
Discrimination
bias lower
— Yes Yes–no odor
discrimination
task worse
Discrimination
bias worse
—
Korytowska
and Szmeja19
30 Coffee and
lemon oil
normal
— Coffee and
lemon oil
identification
threshold
decreased
Yes Coffee and
lemon
thresholds
improved
Improvement correlates
with urea blood
concentration
Griep
et al.11
57 Isoamyl
acetate
elevated
— — Yes Isoamyl
acetate
unchanged
Thresholds improve
to normal levels after
successful kidney
transplantation
Peritoneal dialysis
patients also have
increased thresholds
Negative correlation
between olfaction
and blood urea levels
Frasnelli
et al.7
64 n-Butanol
normal
Sniffin’
Sticks lower
Sniffin’
Sticks lower
No — Olfactory function
rated as normal
by CRF patients
Raff
et al.13
31 — — UPSIT
decreased
No — Olfactory scores
correlated to
subjective global
assessment
Correlation of CRP
levels and olfaction
Our data 20 n-Butanol
normal
Acetic acid
elevated
— Sniffin’
Sticks lower
Yes Acetic acid
threshold and
identification
improved
n-Butanol
unchanged
Olfactory function
rated as normal
by CRF patients
Peritoneal dialysis
patients also have
slightly increased
acetic acid thresholds
Abbreviations: CRF, chronic renal failure; CRP, C-reactive protein; UPSIT, University of Pennsylvania Smell Identification Test.
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of hemodialysis showed contradictory results (see Table 1):
unchanged thresholds, worse discrimination but improved
identification. Our findings confirm all previous results, with
improved olfactory identification, unchanged thresholds for
certain odors (n-butanol), and improved thresholds for
previously decreased odors (acetic acid). We further show
that this effect is rather rapid and one hemodialysis session is
sufficient to improve olfactory function. Considering the
large body of literature on the effects of hemodialysis and
kidney transplantation, this is in line with improvements
of almost all sensory modalities after hemodialysis and
transplantation.27–30
The comparison with patients treated by peritoneal
dialysis suggests that olfactory dysfunction in CKD patients
is determined by multiple factors, including circulating
substances that are removed during hemodialysis. It is of
interest to note that the posthemodialysis results in the HD
group are similar to the PD group, confirming that severe
CKD has chronic consequences on olfactory functions.
Besides sensory improvements, different neuropsycho-
logical and cognitive improvements could be evident after
transplantation and also after only one hemodialysis
session.31–33 Consequently, we think that improvements
observed in the present study were not specific to olfactory
function but rather reflect a general improvement of sensory
and cognitive function after hemodialysis in CKD patients.
Especially for olfactory identification, this seems to be
confirmed by a recent study showing that 24-h sleep
deprivation in healthy subjects results in a 10–15% drop of
identification abilities and significant decrease of blood flow
within the pre- and orbitofrontal cortices.34,35 Indeed, the
pre- and orbitofrontal cortex is a region of convergence not
only for taste and smell, but it also plays an important role
in appetite, motivation, and feeding behavior.36–38 This
would also explain why olfactory, gustatory, and appetite
functions have been found to be altered in CKD
patients.14,16,39 As patients with peritoneal dialysis have also
been shown to preserve better cognitive function compared
with hemodialysis patients,40 this central nervous explanation
for olfactory impairment would also corroborate findings in
this study and that by Griep et al.11 that mildly decreased
olfactory function was present in PD patients.
Investigating possible blood markers that explain these
changes in olfactory function have not yet been consistent.
Although Griep et al.11 and Korytowska and Szmeja19 found
urea blood levels to correlate with olfactory function, the
other studies, including the present one, could not confirm
that. However, urea has an influence not only on cognitive
functions41 but also on peripheral nerve conduction,42 and it
could indeed be one of the multiple factors responsible for
sensory and cognitive impairments in HD patients. Total
volume loss after hemodialysis was also not correlated to any
olfactory change, which makes a possible explanation of local
edema within the olfactory mucosa unlikely.
Malnutrition is a major concern in CKD patients and is
associated with increased mortality and morbidity.43 Among
many factors, decreased chemical senses like smell and taste
have been considered a possible contributing factor.39 Despite
previous studies on olfactory function in CKD patients, its
role in CKD-related malnutrition remains open and only a
recent study showed that olfactory function was correlated to
the subjective global assessment score, an indirect evaluation
of malnutrition.13 A similar pattern of lower nutrient intake
and decreased olfactory function has been observed in elderly
subjects.44 On the other hand, there is probably no
straightforward link between decreased olfactory function
and nutrition, as recent data suggest that most patients who
lose smell completely or suffer from severe olfactory
impairment do not consistently lose weight, but remain
often at their initial weight or even increase it.45 Therefore, it
might be that the full function of the chemical senses and
olfaction in particular has been overestimated as a nutritional
drive factor. Anorexia and malnutrition in CKD patients is
probably the result of multiple factors. Motivational,
emotional, and possibly chemosensory functions are influ-
enced by central (probably orbitofrontal cortical) alterations.
In order to establish a scientifically valuable relation between
olfactory function and nutritional status, a longitudinal
follow-up study would be needed.
Although the present data are interesting and further
support a reversible character to olfactory disorders in
chronic renal failure, it has to be kept in mind that the
presented data are based on a rather small group of patients.
This is an undeniable shortcoming of the study and further
prospective and randomized trials are needed to reassess our
findings.
In conclusion, the present results suggest that olfactory
impairments in peritoneal dialysis are less compared with
olfactory dysfunction observed in CKD patients undergoing
hemodialysis. However, one hemodialysis session is sufficient
to reverse the olfactory decrease, confirming former findings
that kidney transplantation patients have normal olfactory
function. The exact origin of the olfactory impairment in
CKD patients remains unknown. Based on previous literature
on CKD patients, it is suggested that this is mainly an
epiphenomenon of general cognitive and sensory alterations
in CKD.
MATERIALS AND METHODS
Patients and HCS
A total of 20 patients suffering from CKD undergoing HD (mean
age 61±3 years, 4 women and 16 men) 3 sessions a week, 8 patients
under PD (mean age 59±4 years, 2 women and 6 men), and 24
HCS (mean age 57±2 years, 17 women and 7 men) were enrolled in
the study. There was no significant age difference between the three
groups (one-way ANOVA, F¼ 0.5, P¼ 0.6).
Exclusion/inclusion criteria
All subjects underwent extensive nasal endoscopy. In combination
with a detailed history, this procedure ascertained absence of
sinonasal disease in HCS as well as in HD and PD patients. Previous
nasal surgery, medications, and co-morbidities known to signifi-
cantly influence olfactory function were exclusion criteria. The
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present investigation was an observational and preliminary study.
Inclusion criteria were stable outpatients with maintenance PD or
HD. All experimental procedures were explained and demonstrated
in full and all subjects provided informed consent. The study was
conducted according to the Declaration of Helsinki Principles on
Biomedical Research Involving Human Subjects.
HD and PD
HD and PD were done according to our institutional protocols
(for details, see Wasserfallen et al. and Saudan et al.47,48), whereas
BMI, total weight (volume) loss during hemodialysis, as well as
Kt/V(urea) and PRU were recorded. A detailed overview of the
patient’s characteristics is given in Table 2.
Ratings
Furthermore, all participants were asked to rate their nasal patency,
olfactory function, and the importance they attached to olfaction,
using a 10 cm long visual analog scale. The left-hand end of the scale
was labeled with ‘absent olfactory function’, whereas the right-hand
end was labeled with ‘excellent olfactory function’. The obtained
ratings were expressed as percentage of the total length of the visual
analog scale. For nasal patency and importance attached to
olfaction, the labeling was: ‘totally obstructed nose–totally free nose’
and ‘olfaction is unimportant to me–olfaction is very important to
me’ respectively.
Literature
Search for previous articles on Medline was performed combining
the keywords chronic renal failure, renal failure, hemodialysis and
olfaction, olfactory, hyposmia, anosmia, and smell. Additional studies
were identified through references.
Olfactory testing
All participants had chemosensory function tested using a validated,
commercially available odor identification test. Normative data in
relation to age and gender have been published and updated recently
(‘Sniffin’ Sticks’, Burghart Instruments, Wedel, Germany).49,50 Odors
were presented in felt-tip pens of 14 cm length and 1.3 cm inner
diameter. Instead of dye, the pen’s tampon was saturated with liquid
odorants. For odor presentation, the cap was removed by the
experimenter and the pen’s tip was placed 2 cm in front of both
nostrils for B3 s.
Olfactory identification. Olfactory identification was assessed
by presentation of 12 common odors at suprathreshold odor
concentrations to both nostrils. Subjects were free to sample each
odor as often as necessary before selecting one out of four
descriptors (forced choice) from a list specifically assigned to each
odor. An individual subject’s score could range from 0 (none
correctly recognized) to 12. The presented 12 odors were namely
orange, lemon, apple, banana, leather, peppermint, pineapple,
cloves, cinnamon, turpentine, rose, and coffee.
n-Butanol thresholds. The n-butanol thresholds were assessed
using a single-staircase, three-alternative forced-choice procedure.
In all, 16 dilutions were prepared in a geometric series starting from
a 4% n-butanol solution (dilution ratio 1:2; diluent: propylene
glycol). Three pens were presented in a randomized order, with two
containing the solvent and the third the odorant at a certain
dilution. The patient’s task was to identify the odor-containing pen.
Triplets were presented at intervals of 20 s. Reversal of the staircase
was triggered when the odor was correctly identified in two
successive trials. Threshold was defined as the mean of the last four
out of seven staircase reversals. An individual subject’s threshold
score could range from 0 (threshold not detectable at 4% n-butanol)
to 16 (ceiling effect at lowest n-butanol concentration). The reported
normal threshold values50 for n-butanol are between 7 and 10.
Acetic acid thresholds. Acetic acid thresholds were assessed by
an acetic acid dilution series applied in 250ml brown glass bottles
(neoLab, Heidelberg, Germany). The highest concentration (con-
centration step 1) of acetic acid was 25% (5ml acetic acid in 20ml
deionized water). Up to concentration step 16, the acetic acid
concentration was divided by two on every step increase, reaching
the lowest concentration of 0.00076% acetic acid (concentration
step 16) in a total volume of 25ml. Two glass bottles with only 25ml
of deionized water served as blanks. Presentation was done similarly
to the n-butanol threshold, with three glasses presented as a triplet.
Threshold was defined as the mean of the last four out of seven
staircase reversals. An individual subject’s threshold score could
range from 0 (threshold not detectable at 25% acetic acid) to 16
(ceiling effect at lowest acetic acid concentration).
Learning effect
Olfactory identification testing scores depend upon recognition and
naming of odorants in contrast to the threshold tasks (n-butanol,
acetic acid), which are simple detection tasks. It is believed that
olfactory identification and discrimination reflect more complex
and higher cognitive aspects of olfactory processing compared with
olfactory threshold tests, which seem to reflect more upon the
peripheral olfactory pathways.22,23 As we wanted to eliminate a
learning effect of the identified odors to account for improved
Table 2 | Details of the three investigated groups
Means±s.e.m.
Hemodialysis patients
(HD) (n=20)
Peritoneal dialysis patients
(PD) (n=8)
Control subjects
(n=24) P-value
Age 61±3 years 59±4 years 57±2 years One-way ANOVA (P=0.56)
BMI 24.69±0.53 (kg/m2) 24.68±1.32 (kg/m2) 27.95±1.44 One-way ANOVA (P=0.09)
PRU 65.97±1.08 NA NA NA
Kt/V 1.28±0.04 2.5±0.16 NA Mann–Whitney test (Po0.001)
Dialysis duration 126.6±29.6 months 25.3±8.6 months NA Mann–Whitney test (P=0.1)
Albumina 33.7±0.8 g/l 30.5±1.21 g/l NA Mann–Whitney test (P=0.04)
Normalized protein
catabolic rate
0.95±0.04 (g per kg body
weight per day)
0.96±0.07 (g per kg body
weight per day)
NA Mann–Whitney test (P=0.9)
Urea 21.9±1.2mmol/l 19.2±2.9mmol/l NA Mann–Whitney test (P=0.4)
Abbreviations: ANOVA, analysis of variance; BMI, body mass index; NA, not applicable; PRU, percentage of reduction in urea.
aAlbumin measured by a bromocresol purple dye-binding assay (normal values 35–48 g/l).
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olfactory identification, we tested olfactory identification in the
HCS and HD patients twice within 4 h on the same day. HD patients
did not undergo hemodialysis in between these 4 h. This reflects
approximately the time lapse that chronic renal failure patients had
between testing before and after HD.
Statistical analysis
Results were analyzed using SPSS 15 for Windows (SPSS,
Chicago, IL). Descriptive statistics are presented as means and
s.e.m. Analyses of variance (one-way ANOVA and general linear
model) were used to investigate differences in olfactory function
(identification and both thresholds) between HCS and patients
undergoing either HD or PD (between subject factor ‘group’). Paired
Student’s t-tests were used to investigate the effect of hemodialysis on
olfactory function. The same t-tests were employed for the investi-
gation of two consecutive identification tests in HCS and HD patients
(exclusion of a learning bias in the observed identification results in
chronic renal failure patients). Unpaired t-tests were employed for
the investigation of the self-ratings of olfactory performance between
chronic renal failure patients and HCS. Spearmen correlations were
used to investigate the various dialysis parameters (total volume loss,
Kt/V uremia, and PRU) and the BMI compared with the olfactory
changes during hemodialysis. The Mann–Whitney test was used to
compare the basic characteristics between patients undergoing HD or
PD. The a level was set at 0.05.
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